NUVASIVE INC·4

Mar 29, 1:35 PM ET

NUVASIVE INC 4

4 · NUVASIVE INC · Filed Mar 29, 2005

Insider Transaction Report

Form 4
Period: 2005-03-28
Spangler Jonathan
VP & Chief Patent Counsel
Transactions
  • Sale

    Common Stock

    2005-03-28$12.45/sh7,500$93,38519,484 total
Footnotes (1)
  • [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2004.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -